调节重建揭示了阿尔茨海默氏症疾病中的新型放松调节因素
Marcella Vitória Belém-Souza1,2, Gustavo Barra-Matos1,2, Gilderlanio Santana de Araújo3,4
1Graduate Program in Genetics and Molecular Biology, Institute of Biological Sciences, Federal University of Pará, Belém, 66075-100, Brazil.
Molecular neurobiology
|February 23, 2026
概括
这项研究绘制了阿尔茨海默氏症 (AD) 中的转录因子网络图,确定了关键主调节器 (MR-TFs),该调节器在大脑区域中协调基因放松调节. 这些发现为了解AD的复杂分子机制提供了基础.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,其特征是广泛的转录性放松调节.
- 转录因子 (TFs) 在调节与AD病理相关的基因中发挥着至关重要的作用,包括β-粉样蛋白和酸.
研究的目的:
- 重建以TF为中心的调节网络,并分析阿尔茨海默氏症患者在多个大脑区域的动态.
- 为了确定主调节器 (MR-TFs) 调节AD的基因表达变化.
主要方法:
- 从2,229个死后大脑样本 (ROSMAP,MAYO,MSBB队列) 的大量RNA-seq数据的差异基因表达分析.
- 重建以TF-TF为中心的监管网络和总体监管分析.
- 整合了蛋白质-蛋白质相互作用 (PPI) 数据,实验TF-目标数据和AD遗传风险位置.
主要成果:
- 在多个大脑区域确定了354个主调节器 (MR-TFs),其中副海马环,皮质和小脑显示出最高的数量.
- 规则是中等规模的,中位数为55个目标.
- 确定了新的MR-TFs (例如ADCYAP1,TEAD2,BCL6) 和已知的AD相关基因 (例如BIN1,EGFR,SPI1),加强了它们在AD病变发生中的作用.
结论:
- 建立了一个集成的,以MR-TF为中心的阿尔茨海默病监管网络地图.
- 在AD中,MR-TFs以区域和细胞上下文依赖的方式协调基因放松调节.
- 为神经退行症的机械和转化研究提供了基础.
相关概念视频
Neural Regulation
43.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.6K
Regulated Protein Degradation
9.0K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.0K
Regulated Protein Degradation
3.2K
3.2K
Alzheimer's Disease: Overview
1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K
Regulation of the Unfolded Protein Response
3.1K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.1K
Regulation of Expression Occurs at Multiple Steps
26.6K
Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
26.6K


